In the first survey we were able to collect valuable information on the shortcomings of healthcare and identify the main problems patients faced due to the COVID-19 pandemic.
To find out whether these problems persist or have been solved, we need to know your experience.
Your participation is important to understand the impact of the pandemic on patients with rheumatic diseases and, in this way, to establish measures to reduce the impact and improve the care and quality of life of this group.
The second survey of the REUMAVID project was closed on 22 April. A total of 2,002 responses were registered in
A full session focusing on the REUMAVID project was held on Monday 26 April 2021 at the Annual Conference of
Results from the REUMAVID project are generating wide interest as all five abstracts presented by the REUMAVID working group have
The second survey of the REUMAVID project was closed on 22 April. A total of 2,002 responses were registered in
A full session focusing on the REUMAVID project was held on Monday 26 April 2021 at the Annual Conference of
Results from the REUMAVID project are generating wide interest as all five abstracts presented by the REUMAVID working group have
REUMAVID is a project conducted by the Health & Territory Research (HTR) group of the University of Seville (Spain)
